Aphria, Emblem, Aleafia settle dispute over cancelled supply agreement
Aphria Inc. has reached a deal worth $29.1 million to settle a dispute with Emblem Cannabis Corp. and Aleafia Health Inc.
The settlement ends a disagreement the companies had over Aleafia's decision in 2019 to cancel a supply agreement it had with Aphria.
Aphria CEO Irwin Simon says the deal allows the companies to avoid the distraction and the potential expense of prolonged litigation.
Under the agreement, Emblem, which was acquired by Aleafia in 2019, will receive $15 million in cash, $10 million in Aphria shares and a waiver of claimed receivables.
The companies also agreed to a mutual release of all existing and potential claims and the dismissal of arbitration proceedings that had begun.
Aleafia Health CEO Geoff Benic called the agreement fair to both sides and says it allows his company to move forward with a significantly strengthened balance sheet.
Follow us on Instagram
Connect with us on Linkedin